RxDoctor Payments DataLook up a doctor →

Erik Imel, MD

Pediatric Endocrinology · Indianapolis, INNPI 1326178971

Payments from drug & device makers

$2,724,601in general payments, 2019–2025

Across 468 payments — averaging $5821.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ultragenyx Pharmaceutical Inc.$2M
  • Amgen$296K
  • Neurocrine Biosciences, Inc.$162K
  • AstraZeneca$114K
  • Kyowa Kirin, Inc.$97K
  • Sanofi$45K
  • plus $24K from 5 others
$104,563in research payments, 2019–2025

Across 30 payments — averaging $3485.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Neurocrine Biosciences, Inc.$96K
  • Agios Pharmaceuticals, Inc.$8K
  • Amgen$745

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,724,601 in reported general payments places this provider in the 95th percentile of 27 pediatric endocrinology providers in Indiana.

See all pediatric endocrinology providers in Indiana

Medicare billing

Part B allowed, 2024
$9,743
Medicare patients
59
Services billed
142

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pediatric endocrinology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →